Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082546 | SCV000114588 | likely benign | not specified | 2017-07-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000082546 | SCV000918016 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000860578 | SCV001000675 | benign | Autosomal recessive polycystic kidney disease | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000860578 | SCV001325409 | uncertain significance | Autosomal recessive polycystic kidney disease | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Gene |
RCV001588907 | SCV001816482 | likely benign | not provided | 2021-04-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 12846734, 15108277) |
Natera, |
RCV000860578 | SCV001459389 | likely benign | Autosomal recessive polycystic kidney disease | 2019-08-02 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001588907 | SCV002034208 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001588907 | SCV002035530 | likely benign | not provided | no assertion criteria provided | clinical testing |